Treatment of Recalcitrant Hailey-Hailey Disease With Naltrexone and Dupilumab: A Report of Two Cases.

dupilumab hailey-hailey disease immunity th2 low-dose naltrexone treatment-resistant hailey-hailey disease

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jun 2024
Historique:
accepted: 18 06 2024
medline: 22 7 2024
pubmed: 22 7 2024
entrez: 22 7 2024
Statut: epublish

Résumé

This report presents two cases of patients with long-standing, treatment-resistant Hailey-Hailey disease (HHD) who experienced significant symptom relief through a combination therapy of oral naltrexone and dupilumab injections. The therapeutic potential of targeting the Th2 pathway and Ca

Identifiants

pubmed: 39036106
doi: 10.7759/cureus.62701
pmc: PMC11259094
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

e62701

Informations de copyright

Copyright © 2024, Santoso et al.

Déclaration de conflit d'intérêts

Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

Breanna Santoso (B)

Dermatology, Ohio University Heritage College of Osteopathic Medicine, Dublin, USA.

Rachel Krevh (R)

Dermatology, Northeast Ohio Medical University, Rootstown, USA.

Alexa Israeli (A)

Medical School, Lake Erie College of Osteopathic Medicine, Bradenton, USA.

Austin Cusick (A)

Dermatology, OhioHealth, Grove City, USA.

Dawn Merritt (D)

Dermatology, OhioHealth, Columbus, USA.

Michael Holsinger (M)

Dermatology, OhioHealth, Columbus, USA.

Classifications MeSH